Skip to content

Rapid Therapeutic Science Laboratories, Inc.

CIK 0001575659

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q2 Aug 2023
Net Income (TTM)
−$2.43M
−39.8% YoY Q2 Aug 2023
EPS Diluted (TTM)
—
Q2 Aug 2023
Gross Margin
—
Q2 Aug 2023
Operating Margin
—
Q2 Aug 2023
Net Margin
—
Q2 Aug 2023
Free Cash Flow (TTM)
−$1.33M
Q2 Aug 2023
Cash
$2.16K
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
8.83M sh
Q2 Aug 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings